2018-04-28 (Sa) 2 Cyborgs and a Microphone


This is the page I will publish on alternating Saturdays as soon as Tim and I are ready to start our live broadcast of 2 Cyborgs and a Microphone. We may not start immediately but it means we have all the gears in motion to start.

We'll be talking about cerebrolysin again. The first time we covered the benefits of the treatment based on our research. While Tim and I were researching, we tossed around the idea of doing the treatment ourselves. We agreed that it would be awesome so we ordered the medication and all the necessary syringes. Keep in mind, cerebrolysin needs to be injected. So that's kind of a big deal.


Check out the show page for all our episodes and the Two Cyborgs YouTube channel.

Brian - Left _____ Tim - Right


The rest of the posts for this project have been arranged by date.

First time here?

Completed projects from year 1.

Completed projects from year 2.

Completed projects from year 3.

Completed projects from year 4.

Disclaimer for http://24hourengineer.blogspot.com/ and http://24hourengineer.com/


This disclaimer must be intact and whole. This disclaimer must be included if a project is distributed.

All information in this blog, or linked by this blog, is not to be taken as advice or solicitation. Anyone attempting to replicate, in whole or in part, is responsible for the outcome and procedure. Any loss of functionality, money, property or similar, is the responsibility of those involved in the replication.

All digital communication regarding the email address 24hourengineer@gmail.com becomes the intellectual property of Brian McEvoy. Any information contained within these messages may be distributed or retained at the discretion of Brian McEvoy. Any email sent to this address, or any email account owned by Brian McEvoy, cannot be used to claim property or assets.

Comments to the blog may be utilized or erased at the discretion of the owner. No one posting may claim property or assets based on their post.

This blog, including pictures and text, is copyright to Brian McEvoy.



2018-04-15 (Su)

Comments